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Bacteria remain a major cause of human disease and a
formidable foe of the mammalian immune system. Bacter-
ial entry into normally sterile compartments has long been
recognized as a potential calamity for the mammalian host,
in the most extreme circumstances resulting in circulatory
collapse and multiorgan failure. In contrast to viruses, most
bacteria are self-sufficient, producing their own lipid mem-
branes, cell walls, nucleic acids, and proteins. Although
many synthetic pathways used by bacteria and mammals are
similar, others are subtly different and some are completely
distinct. The mammalian immune system has evolved an
array of mechanisms to recognize and respond to these dis-
tinct bacterial products upon infection. While it has been
appreciated for over a century that the mammalian immune
system uses receptors to specifically recognize bacterial
products and initiate inflammatory defenses upon infection,
the last decade has witnessed the molecular characterization
of a number of remarkable pathways of immune defense
against bacteria.
 
Recognition of signature bacterial products has generally
been considered the domain of the innate immune system
(1). Classically, innate immune receptors for bacterially de-
rived compounds are encoded in the germline and do not
require recombination for function. While it has been esti-
mated that there may be roughly 100 distinct innate im-
mune receptors (also known as pattern recognition recep-
tors [PRRs]), this number is quite small when compared
 
with the 10
 
14
 
–10
 
18
 
 distinct receptors that can be generated
by the adaptive immune system (1). Two of the earliest
identified receptors for bacterial products are the scavenger
receptor (SR) and the mannose receptor (MR). These re-
ceptors function in phagocytosis and endosomal targeting
and are found in macrophages, dendritic cells, and, in cer-
tain tissues, endothelial cells. MR is a 175-kD type I mem-
brane glycoprotein from the calcium-dependent lectin fam-
ily that specifically recognizes carbohydrates bearing large
 
numbers of 
 
a
 
-linked oligo-mannoses, a feature characteris-
tic of microbial carbohydrates. MR uptake can lead to pre-
sentation in the context of MHC class II molecules and
CD1 (2) and can induce cytocidal and proinflammatory
mechanisms. SRs consist of at least five classes of receptors
with distinct structures and ligand binding properties. Class
A SRs are homotrimeric membrane proteins that bind di-
verse ligands, including bacterial cell wall components from
Gram-negative (LPS) or Gram-positive bacteria (lipotei-
choic acid [LTA]) (3, 4). As would be expected, SR-defi-
 
cient mice are more susceptible to 
 
Listeria monocytogenes
 
 or
 
Staphylococcus aureus
 
 infection and septic shock (5, 6).
The recently identified family of mammalian toll-like re-
ceptors (TLRs) and the elucidation of some of their speci-
ficities has dramatically enhanced our understanding of the
innate immune system (7). It is now clear that TLRs serve
as recognition and signaling elements for bacterial sub-
stances as diverse as lipoproteins, peptidoglycan, LPS, LTA,
and bacterial DNA. Thus, TLR-4 is the essential recogni-
tion and signaling element for LPS, while TLR-2 and
TLR-6 play a role in recognition of bacterial lipoproteins
(8). TLR-2 has been implicated in the recognition of bac-
terial peptidoglycan and lipoteichoic acids (9). Recently,
the inflammatory and adjuvant effects of bacterial DNA
were attributed to recognition of hypomethylated CpG se-
quences by the TLR-9 receptor (10).
Many decades ago, investigators recognized that bacterial
culture supernatants harbored substances that readily induce
inflammation by recruiting neutrophils to sites of bacterial
infection and inducing their degranulation (11). Biochemi-
cal analyses revealed that the active components of this pro-
cess were bacterial peptides, specifically small, hydrophobic
 
peptides containing 
 
N
 
-formyl methionine on the NH
 
2
 
 ter-
minus (12). Even tripeptides, such as formyl-Met-Leu-Phe,
could act as potent neutrophil and macrophage chemoat-
tractants (13), and subsequently it was found that humans
have two receptors for these bacterial products, now called
the formyl peptide receptors (FPR1 and FPRL1). These
receptors, like other receptors associated with chemotaxis,
contain seven-transmembrane domains and are coupled to
G proteins (14). Interestingly, although mice and humans
both have versions of these receptors, the human receptor
 
has 
 
z
 
100-fold higher affinity for the f-Met peptides and is
correspondingly more effective at directing inflammatory
cells to sites of infection. Nevertheless, deletion of this re-
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ceptor from mice results in enhanced susceptibility to some
bacterial infections (15).
In contrast to innate immunity, adaptive immunity relies
on recombined antigen receptors and their resulting greater
diversity to recognize bacterial antigens. At the T cell level,
receptor-mediated recognition was thought to be exclusive
for peptides derived from the degradation of pathogen-
derived proteins. However, this idea was turned on its head
when Porcelli and Brenner (16) demonstrated that a subset
of T lymphocytes recognize lipid antigens in the context of
CD1, a non-MHC encoded transmembrane protein with
great structural similarity to MHC class I molecules. Thus,
lipids such as mycolic acid (17), derived from 
 
Mycobacterium
tuberculosis
 
, and lipoarabinomanan (18), derived from 
 
Myco-
bacterium leprae
 
, are bound by CD1 and recognized by a
range of T lymphocytes. Although it remains to be proven
that these T cells play a role in protective immunity to my-
cobacterial infection, the concept that T lymphocyte speci-
ficity is exclusive for pathogen-derived peptides has been
laid to rest.
Figure 1. H2-M3 mobilization upon bacterial infection. Under normal circumstances (top panel), endogenous self-peptides (closed blue symbols) are
generated in the cytosol and presented by classical MHC class Ia molecules. In contrast, empty class Ib molecules (H2-M3) are mostly retained in the ER,
while a few mitochondrial formylated peptides are bound and presented by H2-M3 at the cell surface. After bacterial infection (bottom panel), empty
ER-resident H2-M3 molecules are rapidly loaded with bacterially secreted formylated peptides (open red symbols) and form the majority of H2-M3
complexes on the cell surface. By contrast, peptides derived from bacterial antigens (closed red symbols) that are presented by MHC class Ia molecules are
rare when compared with self-derived peptides. 
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The idea of selectively presenting signature bacterial
molecules to T cells is not exclusive to CD1, however.
Nearly a decade ago, the H2-M3 MHC class Ib molecule
was found to present bacterially derived 
 
N
 
-formyl me-
thionine–containing peptides to CD8 T lymphocytes (19,
20). This fascinating molecule had been discovered earlier
as a restriction element for a very small population of pep-
tides derived from the NH
 
2
 
 terminus of mitochondrially
encoded proteins (21). The finding that 
 
N
 
-formyl me-
thionine was essential for high-affinity binding by H2-M3
suggested that this molecule might play a role in defense
against bacterial infection (22), a good idea that was dem-
onstrated to be correct in the setting of 
 
L. monocytogenes
 
 in-
fection (19, 20). Subsequent identifications of the antigenic
 
L. monocytogenes
 
–derived 
 
N
 
-formyl peptides have enabled
kinetic analyses of H2-M3–restricted T cell responses dur-
ing bacterial infection (23–25). Two studies using highly
quantitative methods to enumerate antigen-specific T cells
have demonstrated that H2-M3–restricted T cell responses
are substantial and occur 
 
z
 
2 d earlier than CD8 T cell re-
sponses restricted by conventional MHC class Ia molecules
(26, 27). The large number of H2-M3–restricted T cells,
achieving frequencies of 5–10% of CD8 T cells in some
mouse strains, and their peak presence in vivo at the time
of bacterial clearance suggest an important role for these T
cells in the development of sterilizing immunity. H2-M3–
restricted T cells are cytolytic and produce TNF and IFN-
 
g
 
,
cytokines associated with antilisterial immunity, further
supporting the concept that H2-M3–restricted T cells par-
ticipate in bacterial clearance (28). The most direct evi-
dence for the role of H2-M3–restricted T cells in protec-
tive immunity comes from recent studies by Seaman et al.
(29). Using mice that lack MHC class Ia molecules, they
demonstrated that bacterial clearance depends almost ex-
clusively on H2-M3–restricted CD8 T lymphocytes. That
H2-M3–restricted T cells can provide protective immunity
has also been demonstrated with the adoptive transfer of
specific T cells (30).
How 
 
N
 
-formyl methionine peptides are processed and
presented by H2-M3 is unclear. Early studies by Kauf-
mann et al. (31) demonstrated that macrophages pulsed
with heat-killed 
 
L. monocytogenes
 
 stimulate “MHC-unre-
stricted” (i.e., what were almost certainly H2-M–restricted)
T cells, a finding that has been confirmed more recently
with H2-M3–restricted CTL clones of defined peptide
specificity (32). While presentation of mitochondrial pep-
tides by H2-M3 appears to depend upon conventional
transport from the cytosol into the endoplasmic reticulum
(ER) by the transporter associated with antigen processing
(TAP) (33), this does not appear to be absolutely necessary
for the presentation of 
 
L. monocytogenes
 
–derived peptides
(32). For example, macrophages derived from TAP
 
2
 
/
 
2
 
mice are capable of presenting fMIGWII, an 
 
L. monocytoge-
nes
 
–derived peptide, to CD8 T cells (32).
Trafficking of newly synthesized H2-M3 molecules dif-
fers significantly from that of conventional MHC class Ia
molecules. Using a specific mAb, Chiu et al. (34) found
that while H2-M3 surface expression is very low in unin-
 
fected cells, exogenous administration of 
 
N
 
-formyl me-
thionine peptides dramatically increases surface expression.
Remarkably, upregulation of most H2-M3 expression is
TAP dependent, suggesting that exogenous peptides enter
the cytosol and are transported into the ER by TAP. H2-M3
molecules appear to be sequestered in the ER for lack of
 
N
 
-formyl methionine–containing peptide ligands and are
released for trafficking to the cell surface upon binding of
bacterial peptides (34). This state of readiness, particularly
for pathogen-derived peptides, distinguishes H2-M3 from
other MHC class I molecules. In the setting of bacterial in-
fection, therefore, the bulk of H2-M3 molecules on the
cell surface will present pathogen-derived peptides, in con-
trast to MHC class Ia molecules, which overwhelmingly
present peptides derived from the degradation of self-pro-
teins (Fig. 1).
Although it has been suspected that H2-M3 presents
peptides from many classes of bacteria, until now the only
pathogen for which H2-M3–mediated antigen presentation
has been definitively demonstrated is 
 
L. monocytogenes
 
. This
has changed with the demonstration by Chun et al. (35) in
this issue that 
 
N
 
-formyl methionine peptides are presented
by macrophages infected with 
 
M. tuberculosis
 
. Using the re-
cently sequenced 
 
M. tuberculosis
 
 genome database as a start-
ing point, these investigators scanned for hydrophobic
peptide sequences containing 
 
N
 
-formyl methionine and
otherwise conforming to the H2-M3 binding groove. The
likelihood of successfully predicting which peptides are
bound by H2-M3 was enhanced by knowledge of the
H2-M3 crystal structure (36). After identifying a number of
peptides, Chun et al. identified those that bound H2-M3
with the greatest affinity and further characterized these.
Remarkably, T cell lines generated by peptide immuniza-
tion of naive mice recognized and lysed 
 
M. tuberculosis
 
–
infected macrophages in an H2-M3–restricted fashion, in-
dicating that mycobacterial peptides are presented on the
macrophage surface. Importantly, mice infected with 
 
M.
tuberculosis
 
 harbored formyl peptide–specific T lymphocytes
that produced IFN-
 
g
 
 upon in vitro stimulation. This re-
markable series of experiments demonstrates the existence
of H2-M3–restricted T cells in the setting of 
 
M. tuberculosis
 
infection, suggesting a role for H2-M3–restricted T cells in
defense against one of the most important bacterial patho-
gens of humankind.
In contrast to 
 
L. monocytogenes
 
, which enters the cytosol
of infected cells by lysing the phagosome (37), 
 
M. tuberculo-
sis
 
 resides in a vacuole during intracellular infection. De-
spite this important difference, 
 
N
 
-formyl methionine pep-
tides from both pathogens are presented by H2-M3. The
finding that presentation of peptides by H2-M3 can be
both TAP dependent and independent suggests that there
may be several trafficking routes directing peptides into the
H2-M3 groove. Thus, it is possible that 
 
M. tuberculosis
 
–
derived peptides access the cytosol and enter the ER in a
TAP-dependent fashion. On the other hand, it is possible
that peptides derived from 
 
M. tuberculosis
 
 follow the TAP-
independent pathway demonstrated for peptides derived
from heat-killed 
 
L. monocytogenes
 
. An important difference 
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between live mycobacteria and heat-killed 
 
L. monocytogenes
 
is that the former use a clever mechanism to modify the
vacuole, specifically by inhibiting acidification by exclud-
ing the proton ATPase, which may interfere with MHC
class II antigen processing (38). Evading presentation by
H2-M3 may be more difficult, perhaps in part due to their
intracellular accumulation.
H2-M3, FPR, TLR, and CD1 have shown us that selec-
tive binding and recognition of bacterial molecules is a host
defense strategy shared by the innate and adaptive arms of
the mammalian immune system. Remarkably, in the set-
ting of infection, CD1 molecules very likely bind the same
glycolipid ligands as TLRs. Indeed, alterations in the lipid
moiety of mycolic acids result in aberrant inflammatory re-
sponses that may, in part, reflect the roles of CD1 or TLRs
in defense against 
 
M. tuberculosis
 
 (39). H2-M3 also shares
the pool of bacterially secreted 
 
N
 
-formyl methionine pep-
tides with the chemotactic formyl peptide receptor. While
it is unclear whether competition between innate and
adaptive immune receptors for the same bacterial molecules
occurs in vivo, it is conceivable that at limiting concentra-
tions, receptors on highly prevalent cells such as neutro-
phils could deplete the local microenvironment of peptides
for binding by less prevalent receptors. This kind of com-
petition, therefore, potentially provides a mechanism for
modulating the relative contributions of innate and adap-
tive inflammatory responses to bacterial infection. The
convergent focus of different immune effector arms on the
same pathogen-derived molecules underlines their impor-
tance as signals of infection but also suggests that the range
of distinct bacterial molecules that can serve as such targets
may be limited.
Although immunization with live, attenuated vaccines
can be highly effective, the issue of potential adverse effects
in immunocompromised individuals is always a bother-
some concern. Therefore, the concept of immunizing and
inducing protective immunity with nonliving components
is tantalizing, but, in the case of intracellular bacterial infec-
tions such as 
 
M. tuberculosis
 
, of unproven utility. Antigens
bound by molecules such as CD1 and H2-M3 are particu-
larly attractive as vaccine targets because they induce T
cell–mediated immunity, but in a fashion that is not con-
strained by conventional MHC restriction. Therefore, the
same bacterial molecules could potentially be used to im-
munize a population of individuals with diverse MHC hap-
lotypes. It is even possible, since these molecules are de-
tected by both the innate and adaptive immune systems,
that these antigens could serve as their own adjuvants. In
this context, the finding that a murine MHC class Ib mole-
cule plays a role in the immune response to 
 
M. tuberculosis
 
,
arguably humanity’s worst bacterial enemy, is exciting.
Chun et al. have taken advantage of two of the great ad-
vances of the last decade: the complete genome sequences
of several important human pathogens and the increasing
number of structurally defined, immune-related molecules.
In the coming years, these invaluable databases will increas-
ingly be recognized as indispensable tools for the study of
antimicrobial immunity. To be sure, we have to remain
 
clever as we investigate immune responses to bacterial
pathogens, but it will certainly be a pleasure to replace
months spent at the bench purifying antigenic peptides
with a short trip on a laptop to the genome databases.
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